Oligomeric compounds for the modulation of ras expression

Details for Australian Patent Application No. 2004209599 (hide)

Owner Santaris Pharma A/S

Inventors Wissenbach, Margit; Hansen, Bo; Thrue, Charlotte Albaek; Petersen, Kamille Dumong; Westergaard, Majken

Agent FB Rice

Pub. Number AU-A-2004209599

PCT Pub. Number WO2004/069992

Priority PA 2003 00184 10.02.03 DK; PA 2003 01539 20.10.03 DK

Filing date 10 February 2004

Wipo publication date 19 August 2004

International Classifications

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069992 Priority application(s): WO2004/069992

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209609-Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long QT syndrome

2004209598-Oligomeric compounds for the modulation of survivin expression